7 results match your criteria: "LIT - Leibniz Institute for Immunotherapy[Affiliation]"

Vascular smooth muscle cells (SMCs) can transition between a quiescent contractile or "differentiated" phenotype and a "proliferative-dedifferentiated" phenotype in response to environmental cues, similar to what in occurs in the wound healing process observed in fibroblasts. When dysregulated, these processes contribute to the development of various lung and cardiovascular diseases such as Chronic Obstructive Pulmonary Disease (COPD). Long non-coding RNAs (lncRNAs) have emerged as key modulators of SMC differentiation and phenotypic changes.

View Article and Find Full Text PDF

D-2-hydroxyglutarate (D-2-HG) accumulates in patients with acute myeloid leukemia (AML) with mutated isocitrate dehydrogenase (IDH) and in other malignancies. D-2-HG suppresses antitumor T-cell immunity but little is known about potential effects on non-malignant myeloid cells. Here we show that D-2-HG impairs human but not murine dendritic cell differentiation, resulting in a tolerogenic phenotype with low major histocompatibility class II expression.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GB) IDH-wildtype is a highly aggressive brain tumor that shows significant resistance to immunotherapy, with the translocator protein 18 kDa (TSPO) playing a key role in this process.* -
  • TSPO expression in GB cells correlates with immune infiltration and resistance to T cell-mediated killing, as it regulates apoptosis pathways and is upregulated in response to cytokines from T cells.* -
  • Targeting TSPO may enhance the effectiveness of immunotherapy for GB by overcoming intrinsic resistance mechanisms and improving the sensitivity of cancer cells to immune attacks.*
View Article and Find Full Text PDF

Reactivation of human cytomegalovirus (HCMV) from latency is a frequent complication following hematopoietic stem cell transplantation (HSCT). The development of acute graft-versus-host disease (GVHD) is a significant risk factor for HCMV disease. Using a murine GVHD model in animals latently infected with murine CMV (MCMV), we studied preventive and therapeutic interventions in this high-risk scenario of HSCT.

View Article and Find Full Text PDF

Development of a Neurotensin-Derived Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS Receptor-Expressing Tumors.

Cancers (Basel)

October 2022

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany.

Overexpression of the neurotensin receptor type 1 (NTSR), a peptide receptor located at the plasma membrane, has been reported for a variety of malignant tumors. Thus, targeting the NTSR with F- or Ga-labeled ligands is considered a straightforward approach towards in vivo imaging of NTSR-expressing tumors via positron emission tomography (PET). The development of suitable peptidic NTSR PET ligands derived from neurotensin is challenging due to proteolytic degradation.

View Article and Find Full Text PDF

Accelerated glycolysis leads to secretion and accumulation of lactate and protons in the tumor environment and determines the efficacy of adoptive T cell and checkpoint inhibition therapy. Here, we analyzed effects of lactic acid on different human CD4 T cell subsets and aimed to increase CD4 T cell resistance towards lactic acid. In all CD4 T cell subsets analyzed, lactic acid inhibited metabolic activity (glycolysis and respiration), cytokine secretion, and cell proliferation.

View Article and Find Full Text PDF